Johnson & Johnson's new, one-dose COVID-19 vaccine is near the end of phase 3 clinical trials. Experts call early trial results "very promising" and say the company could upscale production quickly.
NJ Spotlight News is NJTV's nightly news program. The program covers news across New Jersey with a concentration on government and public policy. It airs each weeknight at 6, 7:30, 11 p.m. and at 6:30 a.m.
Dozens of your favorite THIRTEEN and PBS programs are available to watch on-demand on many popular platforms.
LIVE